Eric C. Ehman

Eric C. Ehman

Auto-generated profile, based on publicly available information

Eric C. Ehman

Department of Radiology, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2016 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
EEEric C. Ehman
Eric C. Ehman
SBSpencer Behr
Spencer Behr
SUSarah E. Umetsu
Sarah E. Umetsu
NFNicholas Fidelman
Nicholas Fidelman
BYBenjamin M. Yeh
Benjamin M. Yeh
THThomas A Hope
Thomas A Hope

7 July 2021 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AVAbhinav Vasudevan
Abhinav Vasudevan
DBDavid H Bruining
David H Bruining
ELEdward Loftus
Edward Loftus
WFWilliam Faubion
William Faubion
EEEric C Ehman
Eric C Ehman
LRLaura Raffals
Laura Raffals
Approach to medical therapy in perianal Crohn’s disease

4 February 2023 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
AIAkitoshi Inoue
Akitoshi Inoue
SSShannon P. Sheedy
Shannon P. Sheedy
MWMichael L. Wells
Michael L. Wells
AMAchille Mileto
Achille Mileto
AGAjit H. Goenka
Ajit H. Goenka
JFJoel G. Fletcher
Joel G. Fletcher

1 August 2024 in Radiology
Verified
Journal Article
Closed access
FRFlorian Rieder
Florian Rieder
MBMark E. Baker
Mark E. Baker
DBDavid H. Bruining
David H. Bruining
JFJeff L. Fidler
Jeff L. Fidler
EEEric C. Ehman
Eric C. Ehman
FCfor the Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium
for the Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium
Stricture length, maximal stricture wall thickness, and maximal associated small bowel dilation at MR enterography can reliably assess Crohn disease stricture severity and serve as eligibility and efficacy criteria in clinical trials.

20 November 2017 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
EEEric C. Ehman
Eric C. Ehman
MTMichael S. Torbenson
Michael S. Torbenson
MWMichael L. Wells
Michael L. Wells
BWBrian T. Welch
Brian T. Welch
STScott M. Thompson
Scott M. Thompson
SVSudhakar Venkatesh
Sudhakar Venkatesh

12 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
SESheida Ebrahimi
Sheida Ebrahimi
ELElin Lundström
Elin Lundström
SBSummer J. Batasin
Summer J. Batasin
EHElisabeth Hedlund
Elisabeth Hedlund
KSKarin Stålberg
Karin Stålberg
RRRebecca A. Rakow-Penner
Rebecca A. Rakow-Penner
The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.